Innate Pharma S.A.
Innate Pharma S.A. (IPHYF) Stock Technical Analysis & Trading Signals
Live technical indicators, trading signals, and momentum insights for Innate Pharma S.A. (PNK:IPHYF).
Disclaimer for Technical Analysis Page
The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full DisclaimerIPHYF Technical Analysis Summary
Innate Pharma S.A. stock currently shows a bearish trend, weighed down by selling pressure and weak momentum.
This mix signals that Innate Pharma S.A. is trading in a balanced range with no clear breakout yet.
RSI (14): 18.31
Stochastic %K: 16.67
Williams %R: -83.33
Rate of Change (ROC): -30.23
Takeaway:Innate Pharma S.A. shows oversold momentum, with rebound potential building.
MACD: -0.19
ADX: 87.76
ATR (14): 0.06
CCI (14): -52.99
Takeaway:Innate Pharma S.A. shows weakening trend signals, with bearish pressure building.
Takeaway:Innate Pharma S.A. trades near the lower channel, signaling strong support and possible rebound.
Overall Takeaway:IPHYF shows mixed signals in money flow analysis.
Bullish Signals
ADX above 20 → strong underlying trend.
Bearish Signals
MACD below signal line → short-term caution on momentum.
MFI above 80 → overbought conditions may limit upside.
RVI below 50 → vigor tilted toward sellers.
Overall Recommendation:Insufficient data to provide a recommendation for Innate Pharma S.A..